Literature DB >> 35378018

Proactive High-Dose IV Iron Is Preferred Therapy in ESKD Patients: COMMENTARY.

Frank Liu1,2.   

Abstract

Entities:  

Keywords:  anemia; chronic kidney disease; debate; dialysis; iron

Mesh：

Substances：

Year:  2021        PMID： 35378018      PMCID： PMC8967635          DOI： 10.34067/KID.0004892021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  8 in total

1.  NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.

Authors: 
Journal:  Am J Kidney Dis       Date:  1997-10       Impact factor: 8.860

Review 2.  Post-PIVOTAL Iron Dosing with Maintenance Hemodialysis.

Authors:  David Collister; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-10       Impact factor: 8.237

Review 3.  Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysis.

Authors:  Steven Fishbane; Hitesh H Shah
Journal:  Hemodial Int       Date:  2017-04-03       Impact factor: 1.812

Review 4.  Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease.

Authors:  Pablo E Pergola; Steven Fishbane; Tomas Ganz
Journal:  Adv Chronic Kidney Dis       Date:  2019-07       Impact factor: 3.620

Review 5.  Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients.

Authors:  Abhijit V Kshirsagar; Xiaojuan Li
Journal:  Adv Chronic Kidney Dis       Date:  2019-07       Impact factor: 3.620

Review 6.  Parenteral versus oral iron therapy for adults and children with chronic kidney disease.

Authors:  Jumana Albaramki; Elisabeth M Hodson; Jonathan C Craig; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

7.  Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.

Authors:  Iain C Macdougall; Claire White; Stefan D Anker; Sunil Bhandari; Kenneth Farrington; Philip A Kalra; John J V McMurray; Heather Murray; Charles R V Tomson; David C Wheeler; Christopher G Winearls; Ian Ford
Journal:  N Engl J Med       Date:  2018-10-26       Impact factor: 91.245

8.  The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.

Authors:  Victor E Pollak; Jonathan A Lorch; Rakesh Shukla; Supriya Satwah
Journal:  BMC Nephrol       Date:  2009-02-26       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.